HOME >> MEDICINE >> NEWS
Mentally ill patients receive fewer cardiovascular procedures than rest of population, Yale study finds

After having heart attacks, patients with mental illnesses are significantly less likely to undergo cardiovascular procedures than patients without mental disorders, Yale researchers say.

"Having a mental disorder reduces a patient's chances of receiving cardiovascular procedures by up to 32 percent," said Benjamin Druss, M.D., assistant professor of psychiatry and epidemiology and public health at Yale School of Medicine. "This difference in care was not based on the severity of cardiac illness, or hospital or regional differences between groups."

Published in the January 26 issue of Journal of The American Medical Association (JAMA), the study looked at a sample of 113,653 patients who had myocardial infarction. Of those, 5,653 were mentally ill.

Druss and his team found that patients with mental disorders were 25 percent less likely to receive angioplasty procedures, 32 percent less likely to undergo coronary bypass surgery and 28 percent less likely to undergo cardiac catheterization than those without mental disorders.

Whatever the reasons, Druss said, the fact that these differences could not be explained by measured clinical factors was cause for concern.

"Patients with mental disorders are a vulnerable population who may be susceptible to inadequate medical care," Druss said. "Further work is needed to better understand factors leading to these differences and their implications for quality and long-term outcomes of their cardiac care."

A number of studies have found race- and sex-based differences in rates of cardiovascular procedures in the United States, but no previous studies have examined this issue for patients with mental disorders.


'"/>

Contact: Karen Peart
kare.peart@yale.edu
203-432-1326
Yale University
25-Jan-2000


Page: 1

Related medicine news :

1. Mentally ill offender treatment and crime reduction act becomes law
2. Mentally ill have higher odds of developing brain, lung cancers
3. Mentally fatigued persons switch to automatic pilot
4. Hormonal treatment improves survival in high-risk prostate cancer patients
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
7. Optical technique identifies vulnerable plaques in cardiac patients
8. NHS target driven culture is failing patients
9. Cardiac deaths peak in sleep hours for patients with sleep apnea
10. Chronic fatigue patients show lower response to placebos
11. Depression linked to insomnia in HIV patients

Post Your Comments:
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located in ... number one best large hotel for families in the United ... annual Travelers’ Choice Awards. , TripAdvisor represents the world’s ... to millions of unbiased and honest traveler reviews. The best ...
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... Feffer LLP ( www.hfesq.com ) is investigating potential claims ... or the "Company") (NASDAQ: ADXS ), concerning ... shareholders. On January 21, 2015, an article ... had misrepresented the clinical data for its ADXS-HPV drug ...
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
Cached News: